Gary are we reading the same presentation? Perhaps
Post# of 15624
With regards to multiple myeloma on page 18 of the presentation there is a reference to the FDA. But aside from that the impression I get is that most of their focus, at least for now, is elsewhere.
http://www.owcpharma.com/wp-content/uploads/2...r-2017.pdf